Increased FGF23 is present in rare diseases inducing enthesopathy, such as XLH and ARHR (11, 12, 72, 73), findings that implicate a potential causative role for FGF23 or the resultant hypophosphatemia in its pathogenesis. Here, FGF23 is linked to hypophosphatemia.